National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (A.M.L., D.A.R., L.Y., C.F.W., L.M.N., J.J.B., R.W.E., J.S.S., E.J.E.).
The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (A.A.A.).
Ann Intern Med. 2021 Jul;174(7):999-1003. doi: 10.7326/M21-1043. Epub 2021 Mar 30.
Over the past year, the SARS-CoV-2 pandemic has swept the globe, resulting in an enormous worldwide burden of infection and mortality. However, the additional toll resulting from long-term consequences of the pandemic has yet to be tallied. Heterogeneous disease manifestations and syndromes are now recognized among some persons after their initial recovery from SARS-CoV-2 infection, representing in the broadest sense a failure to return to a baseline state of health after acute SARS-CoV-2 infection. On 3 to 4 December 2020, the National Institute of Allergy and Infectious Diseases, in collaboration with other Institutes and Centers of the National Institutes of Health, convened a virtual workshop to summarize existing knowledge on postacute COVID-19 and to identify key knowledge gaps regarding this condition.
在过去的一年中,SARS-CoV-2 大流行席卷全球,导致了巨大的全球感染和死亡率负担。然而,大流行带来的长期后果所造成的额外损失尚未统计。一些人在最初从 SARS-CoV-2 感染中康复后,现在表现出不同的疾病表现和综合征,广义上讲,这代表急性 SARS-CoV-2 感染后未能恢复到健康的基线状态。2020 年 12 月 3 日至 4 日,美国国立过敏和传染病研究所与国立卫生研究院的其他研究所和中心合作,召开了一次虚拟研讨会,总结了关于急性 COVID-19 的现有知识,并确定了关于这种情况的关键知识空白。